Gadolinium MRI Lawsuits

Apply for a Settlement Loan Now!

Nephrogenic Systemic Fibrosis (NSF)
Nephrogenic Fibrosing Dermopathy (NFD)

TriMark Legal Funding Delivers FAST Gadolinium MRI Settlement Advances

Have You Been Diagnosed With Nephrogenic Systemic Fibrosis (NSF)?
Call Now For a Fast, Affordable, Risk-Free Pre Settlement Loan or Cash Advance

The Gadolinium | NSF | MRI Link

Gadolinium metal

Gadolinium, used as a MRI contrast dye has been linked to NSF, a catastrophic disease with debilitating effects on the body.

The effects can be so devastating in fact that it is common for victims to find themselves immobilized and unable to move around or work within weeks of the onset of symptoms. As a result, many struggle to have enough money to pay for bills, medical treatment and basic living expenses.

Visit Our Blog:

Gadolinium Victim

So far, many of the Gadolinium MRI contrast settlements have been quite large, as they should be, however, because of the speed at which Gadolinium side effects tend to present themselves, until the money actually arrives, most plaintiffs are able to benefit greatly from a a pre settlement loan or lawsuit loan*. It can give plaintiffs the money they need to do the things they want to do now, before it's too late, and otherwise get their finances in order.

Settlement funding or a lawsuit cash advance can give plaintiffs the money they need now to get by until their full settlement comes through. It also allows them to enjoy a higher qualify of life while they are still mobile enough to take full advantage of it.

Gadolinium MRI Dye Causes Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis is a rare, serious, progressive disorder that involves fibrosis or hardening or tightening of the skin, joints, eyes and internal organs.

As more information becomes available, we're discovering that NSF attacks different people in different ways. One thing that is consistent however, is that the cause of NSF seems to be associated exclusively with exposure to Gadolinium in patients with severe kidney failure.

Settlements: Quick and Quiet

In pre settlement funding terminology, NSF is what we refer to as a "signature disease" with regard to liability . This is because NSF does not occur naturally so it cannot be marginalized, explained away or blamed on any other cause like most other medical conditions can be. The ONLY known cause of NSF to date is by exposure to Gadolinium MRI contrast dye.

This points the "smoking gun" of liability directly at the companies who make the MRI dye and may explain why settlements have typically been very large and have been handled relatively quickly & quietly to avoid attracting unwanted attention.

100% RISK-FREE LAWSUIT LOANS & PRE SETTLEMENT CASH ADVANCES!
Our Gadolinium pre settlement funding is "non-recourse". That means if your case doesn't settle, you owe us NOTHING!
It's as simple as that.

Nationwide Litigation Financing Company
TriMark Legal Funding is a division of TriMark Capital Funding, Inc.
Call Now for Lawsuit Funding
TriMark Legal Funding; the lawsuit funding company preferred by more attorneys nationwide. We provide plaintiff settlement funding, attorney funding & law firm loans / financing.
Vioxx Class Action Lawsuit Settlement Funding
Lawsuit Funding - Apply Now!
Other Pharmaceutical Lawsuits Eligible for Lawsuit Loans
Bookmark and Share
Subscribe!

Pre Settlement Funding on Gadolinium MRI Cases
Providing Settlement Advances to Plaintiffs Afflicted with Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis | Nephrogenic Fibrosing Dermopathy

MRI scan Gadolinium contrasting agents

Nephrogenic Systemic Fibrosis (NSF), formerly known as Nephrogenic Fibrosing Dermopathy (NFD), (dermopathy means disorder of skin) is a condition that, to date, has occurred only in people with severe kidney disease who have undergone one or more MRI's.

Gadolinium Victim

NSF is a bizarre systemic disorder with its most prominent and visible effects in the skin. As hundreds of additional emerging cases are studied, it is becoming clear that kidney disease seems to be a prerequisite for developing NSF because all currently known cases of NSF involve patients suffering from severe kidney dysfunction. Nephrogenic means starting with the kidney, so NSF (as opposed to NFD) is accepted as the terminology most accurately reflecting the disease.

What Is Gadolinium?

Gadolinium is a soft, malleable, silvery white rare earth metal that is never found in nature as the free element, but is contained in many rare minerals such as monazite and bastnäsite. It's symbol on the periodic chart of elements is Gd.

What Is Gadolinium MRI Contrast Agent?

Omniscan®
(Gadodiamide)
Approved by FDA on 1/8/1993
Manufacturer: GE Healthcare

OptiMARK®
(Gadoversetamide)
Approved by FDA on 12/8/1999
Manufacturer: Mallinckrodt
Manufacturer: Tyco Healthcare

Magnevist®
(Gadopentetate Dimeglumine)
Approved by FDA on 6/2/1988
Manufacturer: Bayer HealthCare
Manufacturer: Schering AG
Manufacturer: Berlex

ProHance®
(Gadoteridol)
Approved by FDA on 11/16/1992
Manufacturer: Bracco Diagnostics

MultiHance®
Approved by FDA on 11/23/1994
(Gadobenate Dimeglumine)
Manufacturer: Bracco Diagnostics

Gadolinium MRI Scan

Gadolinium is an element that is used in contrast dyes for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). It helps doctors to better distinguish between blood vessels and nearby tissue.

The first toxic side effects of Gadolinium were discovered in 1997. Since that time, more than 1,000 cases have been diagnosed worldwide.

On May 23, 2007 the FDA issued a public health advisory and cited recent findings that clearly indicated Gadolinium-based MRI contrasting agents significantly increased the risk of developing Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD).

Request Settlement Funding Now

There are five different Gadolinium MRI contrasting agents approved for use in the United States. They are Omniscan® (Gadodiamide) manufactured by GE Healthcare, OptiMARK® (Gadoversetamide) manufactured by Mallinckrodt and Tyco Healthcare, Magnevist® (Gadopentetate Dimeglumine) made by Bayer HealthCare, Berlex and Schering AG; ProHance® (Gadoteridol) and MultiHance® (Gadobenate Dimeglumine) both made by Bracco Diagnostics.

Nephrogenic Systemic Fibrosis Symptoms

People with NSF develop fibrosis of the skin and this may spread to the connective tissues and other organs of body. Some of the most common side effects include:

Gadolinium Victim
  • Woody skin with texture of an orange peel
  • Swelling and tightening of the skin
  • Muscle weakness
  • Difficulty flexing and extending the joints
  • Loss of mobility
  • Locking joints
  • Pain in the hip or rib areas
  • Eye discoloration (yellow spots on the eyes)
  • Fibrosis of the skin and internal organs, skin thickening and waxing
  • Red or dark skin patches and skin rashes
  • Blister-like lesions
  • Burning and itching skin
Nephrogenic Systemic Fibrosis Settlement Loan

Nephrogenic Systemic Fibrosis

Recently, a number of Gadolinium lawsuits have been launched in response to the US Food and Drug Administration (FDA) announcement that Gadolinium-containing MRI contrast agents have been identified ad the cause of Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy in patients with kidney disease.

Settlement Funding on Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy is a relatively new medical syndrome and as more cases are discovered, researchers are beginning to understand more about it and are slowly getting a clearer medical picture of the disease.

What is known is that NSF is a progressive, currently incurable and irreversible disorder which causes the development of excessive scar tissue and thick, tight, hardened areas of skin which often cover the joints, resulting in severe limitations on movement. It frequently renders the victim unable to walk or fully move the joints of their arms, hands, legs and/or feet and many become dependent on a wheelchair within weeks of the onset.

There is currently no known cure or effective treatment for Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy and the disease can be excruciatingly painful, debilitating and has, in a number of cases so far, lead to death.

Lawsuit Funding: Make Your Life Easier With a Lawsuit Loan

Getting a lawsuit pre future settlement funding is simple and easy as long as you have a diagnosed case of NSF. Lawsuit funding is fast, free and easy to apply for and with no credit checks, no income or employment requirements, no monthly payments and no up-front or out-of-pocket costs, settlement loans are 100% RISK-FREE for plaintiffs and you only repay the advance if you win your case. If you lose your case or your case doesn't settle, YOU OWE US NOTHING! And with the growing number of Gadolinium cases, litigation financing is an excellent way for attorneys and law firms to to build or expand their practice.

A GADOLINIUM LAWSUIT CASH ADVANCE COULD PUT CASH IN YOUR HANDS IN AS LITTLE AS 48-72 HOURS!
No monthly payments
No employment requirements
Bad credit is no problem
No credit is no problem
No up-front fees or costs
No out-of-pocket expenses
No interference with case management
No payment until your case settles
No payment if your case doesn't settle
Approval process is FAST & EASY
GUARANTEED LOW RATES!
Prompt, professional & VERY DISCREET

THERE'S ZERO RISK ... SO WHY WAIT?

Does your Gadolinium MRI case qualify for lawsuit financing?
Find out now by calling us at 1-877-932-2628 or simply complete the info below.

Gadolinium Lawsuit Settlement Funding - Quick Contact Request

Plaintiff First & Last Name
Primary Email Address
Home Phone (xxx-xxx-xxxx)
Cell Phone (xxx-xxx-xxxx)
Type of Case
Dollar Amount Requested

Serving these cities & states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin and Wyoming. AL, AK, AZ, AR, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE, NV, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WI, WV & WY.